Virtues of being faithful

Can we limit the genetic variation in human immunodeficiency virus?

William C. Drosopoulos, Lisa F. Rezende, Mark A. Wainberg, Vinayaka R. Prasad

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV) infections are characterized by a high degree of viral variation. The genetic variation is thought to be a combined effect of a high error rate of reverse transcriptase (RT), viral genomic recombination, the selection forces of the human immune system, the requirement for growth in multiple cell types during pathogenesis, and persistent immune activation associated with HIV disease. This hypermutability gives the virus an ability to escape mechanisms of innate immune surveillance and therapeutic interventions. Indeed, HIV variants that are resistant to drugs that antagonize both the HIV protease and RT enzymes are well described. Furthermore, there are seemingly no procedures to restrict this disarming property of HIV to mutate rapidly. Recently we have shown that some of the drug-resistant RTs display an increased in vitro polymerase fidelity. The question is whether this finding will stimulate new approaches that will not only help the immune system to deal with the virus more efficiently but also to reduce or delay resistance to various classes of anti-HIV drugs. The pros and cons of this concept and the influence of viral replication rates and viral fitness on HIV variability are discussed.

Original languageEnglish (US)
Pages (from-to)604-612
Number of pages9
JournalJournal of Molecular Medicine
Volume76
Issue number9
DOIs
StatePublished - 1998

Fingerprint

HIV
Virus Diseases
Immune System
Pharmaceutical Preparations
Viruses
HIV Reverse Transcriptase
Aptitude
RNA-Directed DNA Polymerase
Genetic Recombination
Peptide Hydrolases
Enzymes
Growth
Therapeutics

Keywords

  • Escape mutants
  • Fidelity
  • Genetic variation
  • HIV/AIDS

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Virtues of being faithful : Can we limit the genetic variation in human immunodeficiency virus? / Drosopoulos, William C.; Rezende, Lisa F.; Wainberg, Mark A.; Prasad, Vinayaka R.

In: Journal of Molecular Medicine, Vol. 76, No. 9, 1998, p. 604-612.

Research output: Contribution to journalArticle

@article{c607f2f6d737483fb5feb9742bb954f1,
title = "Virtues of being faithful: Can we limit the genetic variation in human immunodeficiency virus?",
abstract = "Human immunodeficiency virus (HIV) infections are characterized by a high degree of viral variation. The genetic variation is thought to be a combined effect of a high error rate of reverse transcriptase (RT), viral genomic recombination, the selection forces of the human immune system, the requirement for growth in multiple cell types during pathogenesis, and persistent immune activation associated with HIV disease. This hypermutability gives the virus an ability to escape mechanisms of innate immune surveillance and therapeutic interventions. Indeed, HIV variants that are resistant to drugs that antagonize both the HIV protease and RT enzymes are well described. Furthermore, there are seemingly no procedures to restrict this disarming property of HIV to mutate rapidly. Recently we have shown that some of the drug-resistant RTs display an increased in vitro polymerase fidelity. The question is whether this finding will stimulate new approaches that will not only help the immune system to deal with the virus more efficiently but also to reduce or delay resistance to various classes of anti-HIV drugs. The pros and cons of this concept and the influence of viral replication rates and viral fitness on HIV variability are discussed.",
keywords = "Escape mutants, Fidelity, Genetic variation, HIV/AIDS",
author = "Drosopoulos, {William C.} and Rezende, {Lisa F.} and Wainberg, {Mark A.} and Prasad, {Vinayaka R.}",
year = "1998",
doi = "10.1007/s001090050257",
language = "English (US)",
volume = "76",
pages = "604--612",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
number = "9",

}

TY - JOUR

T1 - Virtues of being faithful

T2 - Can we limit the genetic variation in human immunodeficiency virus?

AU - Drosopoulos, William C.

AU - Rezende, Lisa F.

AU - Wainberg, Mark A.

AU - Prasad, Vinayaka R.

PY - 1998

Y1 - 1998

N2 - Human immunodeficiency virus (HIV) infections are characterized by a high degree of viral variation. The genetic variation is thought to be a combined effect of a high error rate of reverse transcriptase (RT), viral genomic recombination, the selection forces of the human immune system, the requirement for growth in multiple cell types during pathogenesis, and persistent immune activation associated with HIV disease. This hypermutability gives the virus an ability to escape mechanisms of innate immune surveillance and therapeutic interventions. Indeed, HIV variants that are resistant to drugs that antagonize both the HIV protease and RT enzymes are well described. Furthermore, there are seemingly no procedures to restrict this disarming property of HIV to mutate rapidly. Recently we have shown that some of the drug-resistant RTs display an increased in vitro polymerase fidelity. The question is whether this finding will stimulate new approaches that will not only help the immune system to deal with the virus more efficiently but also to reduce or delay resistance to various classes of anti-HIV drugs. The pros and cons of this concept and the influence of viral replication rates and viral fitness on HIV variability are discussed.

AB - Human immunodeficiency virus (HIV) infections are characterized by a high degree of viral variation. The genetic variation is thought to be a combined effect of a high error rate of reverse transcriptase (RT), viral genomic recombination, the selection forces of the human immune system, the requirement for growth in multiple cell types during pathogenesis, and persistent immune activation associated with HIV disease. This hypermutability gives the virus an ability to escape mechanisms of innate immune surveillance and therapeutic interventions. Indeed, HIV variants that are resistant to drugs that antagonize both the HIV protease and RT enzymes are well described. Furthermore, there are seemingly no procedures to restrict this disarming property of HIV to mutate rapidly. Recently we have shown that some of the drug-resistant RTs display an increased in vitro polymerase fidelity. The question is whether this finding will stimulate new approaches that will not only help the immune system to deal with the virus more efficiently but also to reduce or delay resistance to various classes of anti-HIV drugs. The pros and cons of this concept and the influence of viral replication rates and viral fitness on HIV variability are discussed.

KW - Escape mutants

KW - Fidelity

KW - Genetic variation

KW - HIV/AIDS

UR - http://www.scopus.com/inward/record.url?scp=0031831625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031831625&partnerID=8YFLogxK

U2 - 10.1007/s001090050257

DO - 10.1007/s001090050257

M3 - Article

VL - 76

SP - 604

EP - 612

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 9

ER -